DTIL
Price
$0.43
Change
+$0.01 (+2.38%)
Updated
Sep 20, 6:59 PM EST
54 days until earnings call
EDIT
Price
$7.79
Change
-$0.17 (-2.14%)
Updated
Sep 21, 8:47 AM EST
48 days until earnings call

Compare predictions DTIL vs EDIT

Header iconDTIL vs EDIT Comparison
Open Charts DTIL vs EDITBanner chart's image
Precision BioSciences
Price$0.43
Change+$0.01 (+2.38%)
Volume$562.22K
CapitalizationN/A
Editas Medicine
Price$7.79
Change-$0.17 (-2.14%)
Volume$850
CapitalizationN/A
View a ticker or compare two or three
DTIL vs EDIT Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
DTIL vs. EDIT commentary
Sep 21, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a StrongBuy and EDIT is a Hold.

COMPARISON
Comparison
Sep 21, 2023
Stock price -- (DTIL: $0.43 vs. EDIT: $7.95)
Brand notoriety: DTIL and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 68% vs. EDIT: 75%
Market capitalization -- DTIL: $47.21M vs. EDIT: $653.88M
DTIL [@Biotechnology] is valued at $47.21M. EDIT’s [@Biotechnology] market capitalization is $653.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $424.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 1 FA rating(s) are green whileEDIT’s FA Score has 0 green FA rating(s).

  • DTIL’s FA Score: 1 green, 4 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than DTIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 5 TA indicator(s) are bullish while EDIT’s TA Score has 5 bullish TA indicator(s).

  • DTIL’s TA Score: 5 bullish, 3 bearish.
  • EDIT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DTIL is a better buy in the short-term than EDIT.

Price Growth

DTIL (@Biotechnology) experienced а +0.05% price change this week, while EDIT (@Biotechnology) price change was -6.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.61%. For the same industry, the average monthly price growth was +23.29%, and the average quarterly price growth was +30.30%.

Reported Earning Dates

DTIL is expected to report earnings on Nov 14, 2023.

EDIT is expected to report earnings on Nov 08, 2023.

Industries' Descriptions

@Biotechnology (-1.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for DTIL with price predictions.
OPEN
A.I.dvisor published
a Summary for EDIT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
EDIT($654M) has a higher market cap than DTIL($47.2M). EDIT YTD gains are higher at: -10.372 vs. DTIL (-63.866). DTIL has higher annual earnings (EBITDA): -78.23M vs. EDIT (-209.76M). EDIT has more cash in the bank: 432M vs. DTIL (138M). DTIL has less debt than EDIT: DTIL (28M) vs EDIT (37.2M). DTIL has higher revenues than EDIT: DTIL (46.5M) vs EDIT (19.3M).
DTILEDITDTIL / EDIT
Capitalization47.2M654M7%
EBITDA-78.23M-209.76M37%
Gain YTD-63.866-10.372616%
P/E RatioN/AN/A-
Revenue46.5M19.3M241%
Total Cash138M432M32%
Total Debt28M37.2M75%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DTILEDIT
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UL50.670.18
+0.36%
Unilever plc
VIRX1.12N/A
N/A
Viracta Therapeutics
VLD1.49N/A
N/A
Velo3D
SPHR36.52-0.13
-0.35%
Sphere Entertainment Co
AYI164.70-1.31
-0.79%
Acuity Brands

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
+1.34%
AXON - DTIL
46%
Loosely correlated
-0.22%
NTLA - DTIL
44%
Loosely correlated
-1.11%
BEAM - DTIL
42%
Loosely correlated
+2.98%
RXRX - DTIL
41%
Loosely correlated
-3.67%
ORMP - DTIL
41%
Loosely correlated
-3.83%
More